Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Naik GS"'
Publikováno v:
RGUHS Journal of Medical Sciences. 9
Central venous catheter insertion is a routine practice in intensive care unit patients. Its use is associated with both mechanical and infectious complications. Central venous catheter-related blood stream infections are important cause of hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d94e0a70920e6de78ce243047b7db07c
https://doi.org/10.26463/rjms.9_1_2
https://doi.org/10.26463/rjms.9_1_2
Publikováno v:
Current Medical Research & Opinion; Jun2008, Vol. 24 Issue 6, p1771-1779, 9p
Autor:
Zhong W; Merck & Co., Inc., Rahway, New Jersey, USA., Ma J; Merck & Co., Inc., Rahway, New Jersey, USA., Chen C; Merck & Co., Inc., Rahway, New Jersey, USA., Dettman EJ; Merck & Co., Inc., Rahway, New Jersey, USA., Cristescu R; Merck & Co., Inc., Rahway, New Jersey, USA., Naik GS; Merck & Co., Inc., Rahway, New Jersey, USA., Jin F; Merck & Co., Inc., Rahway, New Jersey, USA., Shao C; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (11), pp. e7358.
Autor:
Davar D; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania., Zappasodi R; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, New York., Wang H; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania., Naik GS; Leap Therapeutics, Cambridge, Massachusetts., Sato T; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., Bauer T; Phase I Drug Development Unit, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, Tennessee., Bajor D; Department of Medicine and Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Rixe O; University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico., Newman W; Leap Therapeutics, Cambridge, Massachusetts., Qi J; Immune Monitoring Facility, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Holland A; Immune Monitoring Facility, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Wong P; Immune Monitoring Facility, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Sifferlen L; Leap Therapeutics, Cambridge, Massachusetts., Piper D; Leap Therapeutics, Cambridge, Massachusetts., Sirard CA; Leap Therapeutics, Cambridge, Massachusetts., Merghoub T; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Wolchok JD; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Luke JJ; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Sep 15; Vol. 28 (18), pp. 3990-4002.
Autor:
Klempner SJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. sklempner@partners.org., Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee., Villaflor VM; Northwestern University, Chicago, Illinois., Tenner LL; University of Texas Health Science Center, San Antonio, Texas., Stein SM; Yale School of Medicine, New Haven, Connecticut., Rottman JB; Athenaeum Pathology Consulting, LLC, Sudbury, Massachusetts., Naik GS; Leap Therapeutics, Cambridge, Massachusetts., Sirard CA; Leap Therapeutics, Cambridge, Massachusetts., Kagey MH; Leap Therapeutics, Cambridge, Massachusetts., Chaney MF; Merck & Co., Inc., Kenilworth, New Jersey., Strickler JH; Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Nov; Vol. 20 (11), pp. 2240-2249. Date of Electronic Publication: 2021 Sep 04.
Autor:
Naik GS; Department of Medical Oncology, Dana-Farber Cancer Institute.; Harvard Medical School., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute.; Harvard Medical School.; Brigham and Women's Hospital., Cohen JV; Harvard Medical School.; Center for Melanoma, Massachusetts General Hospital, Boston., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute., Johnson AEW; Institute of Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA., Bowling P; Department of Medical Oncology, Dana-Farber Cancer Institute., Aizer AA; Harvard Medical School.; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center., Schoenfeld JD; Harvard Medical School.; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center., Lawrence DP; Harvard Medical School.; Center for Melanoma, Massachusetts General Hospital, Boston., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute.; Harvard Medical School.; Brigham and Women's Hospital., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute.; Harvard Medical School.; Brigham and Women's Hospital., Sullivan RJ; Harvard Medical School.; Center for Melanoma, Massachusetts General Hospital, Boston., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute.; Harvard Medical School.; Brigham and Women's Hospital.
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2021 Oct 01; Vol. 44 (8), pp. 307-318.
Autor:
Miller BC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Sen DR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Al Abosy R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bi K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Virkud YV; Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA., LaFleur MW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Yates KB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lako A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Felt K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Naik GS; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gjini E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuchroo JR; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Ishizuka JJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Collier JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Griffin GK; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Maleri S; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Comstock DE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Weiss SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Brown FD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Panda A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Zimmer MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sharpe AH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Haining WN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wnhaining@gmail.com.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. wnhaining@gmail.com.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA. wnhaining@gmail.com.
Publikováno v:
Nature immunology [Nat Immunol] 2019 Nov; Vol. 20 (11), pp. 1556.
Autor:
Naik GS; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Waikar SS; Harvard Medical School, Boston, MA, USA.; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Johnson AEW; Institute of Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Schoenfeld JD; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Patrick_Ott@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Patrick_Ott@dfci.harvard.edu.; Melanoma Center & Center for Immuno-Oncology, Boston, MA, USA. Patrick_Ott@dfci.harvard.edu.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Mar 29; Vol. 7 (1), pp. 89. Date of Electronic Publication: 2019 Mar 29.
Autor:
Miller BC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Sen DR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Al Abosy R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bi K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Virkud YV; Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA., LaFleur MW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Yates KB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lako A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Felt K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Naik GS; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gjini E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuchroo JR; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Ishizuka JJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Collier JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Griffin GK; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Maleri S; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Comstock DE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Weiss SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Brown FD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Panda A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Zimmer MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sharpe AH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Haining WN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wnhaining@gmail.com.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. wnhaining@gmail.com.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA. wnhaining@gmail.com.
Publikováno v:
Nature immunology [Nat Immunol] 2019 Mar; Vol. 20 (3), pp. 326-336. Date of Electronic Publication: 2019 Feb 18.
Autor:
Kaul S; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India., Alladi S; Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bengaluru, Karnataka, India., Jabeen SA; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India., Bandaru VCSSR; Department of Neurology and Clinical Research, Yashoda Hospital, Hyderabad, Telangana, India., Ankem U; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India., Mekala S; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India., Naik GS; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
Publikováno v:
Annals of Indian Academy of Neurology [Ann Indian Acad Neurol] 2018 Jul-Sep; Vol. 21 (3), pp. 209-213.